These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 18175065)

  • 1. Chronic kidney disease perspectives in Japan and the importance of urinalysis screening.
    Yamagata K; Iseki K; Nitta K; Imai H; Iino Y; Matsuo S; Makino H; Hishida A
    Clin Exp Nephrol; 2008 Feb; 12(1):1-8. PubMed ID: 18175065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age distribution and yearly changes in the incidence of ESRD in Japan.
    Yamagata K; Takahashi H; Suzuki S; Mase K; Hagiwara M; Shimizu Y; Hirayama K; Kobayashi M; Narita M; Koyama A
    Am J Kidney Dis; 2004 Mar; 43(3):433-43. PubMed ID: 14981601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinuria screening for children.
    Murakami M; Hayakawa M; Yanagihara T; Hukunaga Y
    Kidney Int Suppl; 2005 Apr; (94):S23-7. PubMed ID: 15752235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of diabetic end-stage renal disease in Japan.
    Iseki K
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S2-6. PubMed ID: 16174282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of asymptomatic hematuria and/or proteinuria in men. High prevalence of IgA nephropathy among proteinuric patients found in mass screening.
    Yamagata K; Takahashi H; Tomida C; Yamagata Y; Koyama A
    Nephron; 2002 May; 91(1):34-42. PubMed ID: 12021517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observation period for changes in proteinuria and risk prediction of end-stage renal disease in general population.
    Usui T; Kanda E; Iseki C; Iseki K; Kashihara N; Nangaku M
    Nephrology (Carlton); 2018 Sep; 23(9):821-829. PubMed ID: 28635004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal outcomes in chronic kidney disease.
    Iseki K
    Nephrology (Carlton); 2010 Jun; 15 Suppl 2():27-30. PubMed ID: 20586944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass urinary screening and follow-up for school children in Taiwan Province.
    Lin CY; Sheng CC; Lin CC; Chen CH; Chou P
    Acta Paediatr Taiwan; 2001; 42(3):134-40. PubMed ID: 11431857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility study of the early detection and treatment of renal disease by mass screening.
    Craig JC; Barratt A; Cumming R; Irwig L; Salkeld G
    Intern Med J; 2002; 32(1-2):6-14. PubMed ID: 11783681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.
    Wakai K; Nakai S; Kikuchi K; Iseki K; Miwa N; Masakane I; Wada A; Shinzato T; Nagura Y; Akiba T
    Nephrol Dial Transplant; 2004 Aug; 19(8):2044-52. PubMed ID: 15173379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of developing end-stage renal disease in a cohort of mass screening.
    Iseki K; Iseki C; Ikemiya Y; Fukiyama K
    Kidney Int; 1996 Mar; 49(3):800-5. PubMed ID: 8648923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenging chronic kidney disease: experience from chronic kidney disease prevention programs in Shanghai, Japan, Taiwan and Australia.
    Chen N; Hsu CC; Yamagata K; Langham R
    Nephrology (Carlton); 2010 Jun; 15 Suppl 2():31-6. PubMed ID: 20586945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nationwide study of mass urine screening tests on Korean school children and implications for chronic kidney disease management.
    Cho BS; Hahn WH; Cheong HI; Lim I; Ko CW; Kim SY; Lee DY; Ha TS; Suh JS
    Clin Exp Nephrol; 2013 Apr; 17(2):205-10. PubMed ID: 23135862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index and the risk of chronic renal failure: the Asian experience.
    Iseki K
    Contrib Nephrol; 2006; 151():42-56. PubMed ID: 16929132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological survey and clinical investigation of pediatric IgA nephropathy.
    Shibano T; Takagi N; Maekawa K; Mae H; Hattori M; Takeshima Y; Tanizawa T
    Clin Exp Nephrol; 2016 Feb; 20(1):111-7. PubMed ID: 26041644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of School Urinary Screening for Early Detection of IgA Nephropathy in Japan.
    Honda K; Akune Y; Goto R
    JAMA Netw Open; 2024 Feb; 7(2):e2356412. PubMed ID: 38363568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinuria and decreased body mass index as a significant risk factor in developing end-stage renal disease.
    Iseki K; Tokashiki K; Iseki C; Kohagura K; Kinjo K; Takishita S
    Clin Exp Nephrol; 2008 Oct; 12(5):363-369. PubMed ID: 18584288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes and predictors for ESRD and mortality in primary GN.
    Chou YH; Lien YC; Hu FC; Lin WC; Kao CC; Lai CF; Chiang WC; Lin SL; Tsai TJ; Wu KD; Chen YM
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1401-8. PubMed ID: 22798538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The underlying diseases and follow-up in Taiwanese children screened by urinalysis.
    Lin CY; Hsieh CC; Chen WP; Yang LY; Wang HH
    Pediatr Nephrol; 2001 Mar; 16(3):232-7. PubMed ID: 11322370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
    Iwakiri T; Fujimoto S; Kitagawa K; Furuichi K; Yamahana J; Matsuura Y; Yamashita A; Uezono S; Shimao Y; Hisanaga S; Tokura T; Wada T; Kitamura K; Asada Y
    BMC Nephrol; 2013 Jun; 14():125. PubMed ID: 23773275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.